D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 60 Citations 10,215 159 World Ranking 1116 National Ranking 477

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Antibiotics
  • Bacteria

His scientific interests lie mostly in Internal medicine, Surgery, Antibiotics, Antibacterial agent and Microbiology. His work carried out in the field of Internal medicine brings together such families of science as Vancomycin and Mycosis. His research is interdisciplinary, bridging the disciplines of Staphylococcus aureus and Surgery.

His work focuses on many connections between Antibiotics and other disciplines, such as Methicillin-resistant Staphylococcus aureus, that overlap with his field of interest in Staphylococcal infections and Minimum inhibitory concentration. In his work, Enterococcus faecalis, Aminoglycoside and Mortality rate is strongly intertwined with Enterococcus, which is a subfield of Antibacterial agent. He interconnects Pseudomonas aeruginosa, Proteus mirabilis and Veterinary medicine in the investigation of issues within Microbiology.

His most cited work include:

  • Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. (277 citations)
  • Candiduria: A Randomized, Double-Blind Study of Treatment with Fluconazole and Placebo (261 citations)
  • Trends in US hospital admissions for skin and soft tissue infections. (248 citations)

What are the main themes of his work throughout his whole career to date?

Marcus J. Zervos mainly investigates Microbiology, Internal medicine, Vancomycin, Methicillin-resistant Staphylococcus aureus and Staphylococcus aureus. His work in the fields of Microbiology, such as Enterococcus faecium, Antibacterial agent and Enterococcus, overlaps with other areas such as Pulsed-field gel electrophoresis. His Internal medicine research incorporates elements of Antibiotics, Surgery and Intensive care medicine.

Marcus J. Zervos focuses mostly in the field of Intensive care medicine, narrowing it down to topics relating to Epidemiology and, in certain cases, Infection control. The various areas that Marcus J. Zervos examines in his Methicillin-resistant Staphylococcus aureus study include Bacteremia and Staphylococcal infections. His study looks at the relationship between Staphylococcus aureus and fields such as Antimicrobial, as well as how they intersect with chemical problems.

He most often published in these fields:

  • Microbiology (52.36%)
  • Internal medicine (42.91%)
  • Vancomycin (34.80%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (42.91%)
  • Methicillin-resistant Staphylococcus aureus (30.74%)
  • Microbiology (52.36%)

In recent papers he was focusing on the following fields of study:

Marcus J. Zervos mainly focuses on Internal medicine, Methicillin-resistant Staphylococcus aureus, Microbiology, Antimicrobial stewardship and Bacteremia. His study in the field of Respiratory failure, Retrospective cohort study, Prospective cohort study and Incidence is also linked to topics like Hydroxychloroquine. The Incidence study which covers Kidney disease that intersects with Intensive care unit and Odds ratio.

His research integrates issues of Enterococcus, Colonization and Vancomycin-resistant Enterococcus in his study of Methicillin-resistant Staphylococcus aureus. His studies in Microbiology integrate themes in fields like Daptomycin resistance and Staphylococcus aureus. Marcus J. Zervos has researched Bacteremia in several fields, including Pseudomonas aeruginosa and Vancomycin, Daptomycin.

Between 2017 and 2021, his most popular works were:

  • Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. (224 citations)
  • Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. (224 citations)
  • Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. (176 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Antibiotics
  • Bacteria

His primary areas of study are Methicillin-resistant Staphylococcus aureus, Internal medicine, Bacteremia, Retrospective cohort study and Vancomycin. Marcus J. Zervos has included themes like Enterococcus, Colonization and Vancomycin-resistant Enterococcus in his Methicillin-resistant Staphylococcus aureus study. Marcus J. Zervos is interested in Prospective cohort study, which is a branch of Internal medicine.

Bacteremia is a subfield of Microbiology that Marcus J. Zervos studies. His Microbiology research is multidisciplinary, relying on both Biomarker, Skin and skin structure infection and Staphylococcus aureus. His Vancomycin research includes elements of Salvage therapy, Antibiotic resistance and Combination therapy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Candiduria: A Randomized, Double-Blind Study of Treatment with Fluconazole and Placebo

J. D. Sobel;C. A. Kauffman;D. McKinsey;M. Zervos.
Clinical Infectious Diseases (2000)

387 Citations

Application of Molecular Techniques to the Study of Hospital Infection

Aparajita Singh;Richard V. Goering;Shabbir Simjee;Steven L. Foley.
Clinical Microbiology Reviews (2006)

379 Citations

Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.

Emanuel N. Vergis;Mary K. Hayden;Joseph W. Chow;David R. Snydman.
Annals of Internal Medicine (2001)

351 Citations

Trends in US hospital admissions for skin and soft tissue infections.

John Edelsberg;Charu Taneja;Marcus Zervos;Nadia Haque.
Emerging Infectious Diseases (2009)

331 Citations

Thrombocytopenia Associated with Linezolid Therapy

Kinan Attassi;Ellie Hershberger;Rabiul Alam;Marcus J. Zervos;Marcus J. Zervos.
Clinical Infectious Diseases (2002)

291 Citations

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.

Samia Arshad;Paul Kilgore;Zohra S. Chaudhry;Gordon Jacobsen.
International Journal of Infectious Diseases (2020)

287 Citations

Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study.

Daniel H Kett;Ennie Cano;Andrew A Quartin;Julie E Mangino.
Lancet Infectious Diseases (2011)

268 Citations

Epidemiology and Outcomes of Community-Associated Methicillin-Resistant Staphylococcus aureus Infection

S. L. Davis;S. L. Davis;M. B. Perri;S. M. Donabedian;C. Manierski.
Journal of Clinical Microbiology (2007)

267 Citations

Bacteremia in Narcotic Addicts at the Detroit Medical Center. II. Infectious Endocarditis: A Prospective Comparative Study

Donald P. Levine;Lawrence R. Crane;Marcus J. Zervos.
Clinical Infectious Diseases (1986)

264 Citations

Pertussis: Microbiology, Disease, Treatment, and Prevention

Paul E. Kilgore;Abdulbaset M. Salim;Marcus J. Zervos;Heinz Josef Schmitt;Heinz Josef Schmitt.
Clinical Microbiology Reviews (2016)

263 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Marcus J. Zervos

Michael J. Rybak

Michael J. Rybak

Eugene Applebaum College of Pharmacy and Health Sciences

Publications: 140

Jack D. Sobel

Jack D. Sobel

Wayne State University

Publications: 50

George Sakoulas

George Sakoulas

University of California, San Diego

Publications: 42

Cesar A. Arias

Cesar A. Arias

The University of Texas Health Science Center at Houston

Publications: 38

Arnold S. Bayer

Arnold S. Bayer

University of California, Los Angeles

Publications: 32

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 31

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 27

Vance G. Fowler

Vance G. Fowler

Duke University

Publications: 26

Loren G. Miller

Loren G. Miller

UCLA Medical Center

Publications: 24

Antoni Torres

Antoni Torres

University of Barcelona

Publications: 22

Keith S. Kaye

Keith S. Kaye

Wayne State University

Publications: 21

Michael S. Niederman

Michael S. Niederman

Cornell University

Publications: 19

Carol A. Kauffman

Carol A. Kauffman

University of Michigan–Ann Arbor

Publications: 19

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 19

Marin H. Kollef

Marin H. Kollef

Washington University in St. Louis

Publications: 19

Henry F. Chambers

Henry F. Chambers

University of California, San Francisco

Publications: 18

Trending Scientists

Vassilis Athitsos

Vassilis Athitsos

The University of Texas at Arlington

Keith R. Ihlanfeldt

Keith R. Ihlanfeldt

Florida State University

Dan Chen

Dan Chen

Wuhan University

Shantanu Sarkar

Shantanu Sarkar

Amazon (United States)

Qingming Li

Qingming Li

University of Manchester

Hiroshi Tamura

Hiroshi Tamura

Juntendo University

Feng Wang

Feng Wang

Dalian Institute of Chemical Physics

Maria João Bebianno

Maria João Bebianno

University of Algarve

John B. Taggart

John B. Taggart

University of Stirling

Fabien Arnaud

Fabien Arnaud

Université Savoie Mont Blanc

Kazushige Obara

Kazushige Obara

University of Tokyo

Philip E. Dennison

Philip E. Dennison

University of Utah

Valérie Camos

Valérie Camos

University of Fribourg

Carla Sharp

Carla Sharp

University of Houston

Stephen F. Lowry

Stephen F. Lowry

Rutgers, The State University of New Jersey

Stanley Luchters

Stanley Luchters

Aga Khan University

Something went wrong. Please try again later.